scispace - formally typeset
M

Masami Ishii

Researcher at University of Tokyo

Publications -  18
Citations -  1430

Masami Ishii is an academic researcher from University of Tokyo. The author has contributed to research in topics: Gene expression & Gene expression profiling. The author has an hindex of 13, co-authored 18 publications receiving 1383 citations. Previous affiliations of Masami Ishii include Kyorin University.

Papers
More filters
Journal Article

Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

TL;DR: This study performs global analysis on differential gene expression of a scirrhous gastric cancer cell line and its derivative sublines with high potential for metastasis to the peritoneal cavity and lymph nodes in a nude mice model and reveals two functional gene clusters with altered expression.
Journal ArticleDOI

Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells.

TL;DR: Microarray analysis of human umbilical vein endothelial cells infected with recombinant adenoviruses carrying a constitutively active form of ALK‐1 or AlK‐5 revealed some new targets of TGF‐β in endothelial Cells, and differences in transcriptional regulation patterns between ALK •1 and ALK•5.
Journal ArticleDOI

Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis.

TL;DR: GeneChip technology is reasonably reliable for quantitative analysis of expression profiling and would be appropriate as a common platform upon which to build a gene expression database.
Journal ArticleDOI

Fish oil feeding alters liver gene expressions to defend against PPARα activation and ROS production

TL;DR: Analysis of gene expression profile of mice liver indicates that fish oil feeding downregulated the endogenous PPARalpha-activation system and increased antioxidant gene expressions to protect against ROS excess.
Journal ArticleDOI

Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein–Taybi syndrome

TL;DR: The results suggest that the loss of the HAT activity of CBP may cause RTS, as the first example of a defect of H AT activity in a human disease, and raise the possibility that treatment of RTS patients with histone deacetylase inhibitors might have beneficial effects.